首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1820385

2025 年至 2033 年病毒过滤市场规模、份额、趋势及预测（依产品、应用、最终用途及地区划分）

Virus Filtration Market Size, Share, Trends and Forecast by Product, Application, End Use, and Region, 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024年，全球病毒过滤市场规模达47亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到98亿美元，2025-2033年期间的复合年增长率（CAGR）为8.04%。全球健康危机频繁、在紧凑的工期下大规模生产生物製药的需求日益增长，以及对新药、新疗法和新疫苗开发的投资不断增加，这些都是推动市场成长的关键因素。

病毒过滤是生物製药生产过程中的关键步骤，旨在确保疫苗、抗体和生物製剂等药品的安全性和纯度。此方法用于去除可能危害人体健康的病毒污染物。在註射用药物的生产中，病毒过滤尤其重要，因为注射用药物直接进入人体，因此需要高纯度标准。通常，使用具有特定孔径的专用薄膜过滤器来捕获和去除病毒。这些过滤器旨在允许所需产品通过，同时有效捕捉病毒颗粒。该工艺在实施前经过严格验证，并定期进行测试以确认其有效性。此外，它也是药品生产的强大保障，可提高产品安全性并符合法规要求。

全球市场主要受全球卫生危机（例如流行病和大规模病毒爆发）的不断升级。这凸显了过滤技术对于确保医疗用品和药品安全的重要性。在这样的时期，对疫苗和其他治疗药物的需求呈指数级增长。这种需求使得必须在紧凑的时间表内大规模生产生物製药，同时又不能损害安全性。因此，这对市场产生了正面的影响。此外，生物製药行业合约生产组织 (CMO) 的兴起是推动市场成长的另一个重要因素。此外，对新药、新疗法和疫苗开发的投资不断增加，而这些投资本身就需要这些流程来确保安全性和合规性，这也大大支持了市场的发展。

病毒过滤市场趋势/驱动因素：

生物製药需求不断成长

病毒过滤产业的重要市场驱动力之一是对单株抗体、重组蛋白和疫苗等生物製药日益增长的需求。这些复杂的分子通常来自活细胞，因此易受病毒污染。此外，癌症、糖尿病和自体免疫疾病等慢性疾病的发生率不断上升，也对市场产生了影响。需求的成长给製造商带来了生产符合严格安全和品质标准的生物製药的负担。病毒过滤在这一领域成为不可或缺的一步，因为它对于确保这些产品的纯度和安全性至关重要。监管机构正在实施严格的病毒清除指南，进一步强调了这些技术的重要性。随着越来越多的生物製药进入市场或进行临床试验，对病毒过滤服务的需求也随之加速，进而推动产业发展。

技术和研究的不断进步

过滤膜和方法领域的技术进步正在显着影响病毒过滤产业的发展。同时，更有效率、可扩展且更具成本效益的过滤系统的开发，使製药公司能够更轻鬆地将这些解决方案整合到现有生产线中。奈米技术和材料科学的创新正在推动过滤器的效率和吞吐能力的提升，从而实现更快速、更可靠的病毒去除。随着过滤技术研发工作的不断推进，该领域的公司正在加大对该技术的采用。这项技术进步提升了製药生产的标准，并成为全球市场的强大驱动力。

更加重视法规遵从性和品质保证

遵守监管标准是病毒过滤产业的必要条件和市场驱动力。各机构对生物衍生药品的病毒安全性有具体的指导方针。这些指导方针通常要求病毒清除的多个步骤，包括病毒过滤。满足这些监管要求对于製药公司获得产品批准和维护市场信誉至关重要。鑑于病毒污染的严重后果，从产品上市延迟到法律责任，对监管合规性的重视是推动病毒过滤技术应用的强大动力。此外，业界也受益于对品质保证的高度重视，使其成为生物製药製造价值链的重要组成部分。

The global virus filtration market size reached USD 4.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 8.04% during 2025-2033. The rising occurrences of global health crises, the growing need for mass production of biopharmaceuticals under tight schedules, and the growing investments in the development of new medicines, therapies, and vaccines are among the key factors driving the market growth.

Virus filtration is a critical step in the biopharmaceutical manufacturing process aimed at ensuring the safety and purity of medicinal products, including vaccines, antibodies, and biologics. This method is employed to remove viral contaminants that could be harmful to human health. It is especially essential in the production of parenteral medications, which are introduced directly into the body and thus require high purity standards. Typically, specialized membrane filters with defined pore sizes are used to capture and remove viruses. These filters are designed to allow the passage of the desired product while effectively trapping viral particles. The process is rigorously validated before implementation, and periodic testing is performed to confirm its effectiveness. Furthermore, it serves as a robust safeguard in pharmaceutical manufacturing, enhancing product safety and compliance with regulatory requirements.

The global market is majorly driven by the escalating occurrence of global health crises such as pandemics and widespread viral outbreaks. This highlights the importance of this filtration technique to ensure the safety of medical supplies and pharmaceuticals. During such times, there is an exponential increase in the demand for vaccines and other therapeutic agents. This demand necessitates the mass production of biopharmaceuticals under tight schedules, without compromising on safety. Therefore, this is positively influencing the market. Along with this, the rise of contract manufacturing organizations (CMOs) in the biopharmaceutical industry is another significant factor contributing to the growth of the market. In addition, the escalating investments in the development of new medicines, therapies, and vaccines, which inherently require these processes for safety and compliance are also significantly supporting the market.

Virus Filtration Market Trends/Drivers:

Increasing demand for biopharmaceuticals

One of the significant market drivers for the virus filtration industry is the growing demand for biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and vaccines. These complex molecules are often derived from living cells, making them susceptible to viral contamination. Along with this, the rising prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders is impacting the market. This increase in demand places a burden on manufacturers to produce biopharmaceuticals that meet stringent safety and quality criteria. Virus filtration becomes an indispensable step in this scenario, as it is crucial for ensuring the purity and safety of these products. Regulatory bodies are imposing strict guidelines for viral clearance, further emphasizing the importance of these technologies. As more biopharmaceuticals enter the market or undergo clinical trials, the need for virus filtration services is accelerating correspondingly, thereby driving the industry forward.

Continual advancements in technology and research

Technological advancements in the field of filtration membranes and methods are significantly impacting the growth of the virus filtration industry. Along with this, the development of more efficient, scalable, and cost-effective filtration systems is making it easier for pharmaceutical companies to integrate these solutions into their existing production lines. Innovations in nanotechnology and material science are leading to filters with higher efficacy and better throughput capabilities, thus enabling more rapid and reliable virus removal. As research and development efforts continue in filtration technology, companies operating in this domain are increasing the adoption of the technology. This technological progress elevates the standard of pharmaceutical manufacturing and serves as a strong market driver for the global market.

An enhanced focus on regulatory compliance and quality assurance

Compliance with regulatory standards is a requirement and a market driver for the virus filtration industry. Agencies have specific guidelines about the viral safety of biologically-derived medicinal products. These guidelines often necessitate multiple steps for viral clearance, including virus filtration. Meeting these regulatory expectations is paramount for pharmaceutical companies to obtain product approvals and maintain market credibility. Given the dire consequences of viral contamination, ranging from delayed product launches to legal liabilities, the emphasis on regulatory compliance acts as a compelling force for the adoption of virus filtration technologies. Moreover, the industry benefits from this heightened focus on quality assurance, making it an essential component in the biopharmaceutical manufacturing value chain.

Virus Filtration Industry Segmentation:

Breakup by Product:

Consumables
- Kits and Reagents
- Others
Instruments
- Filtration Systems
- Chromatography Systems
Services

Consumables hold the largest market share

The market for consumables in the virus filtration industry is experiencing substantial growth, driven by the recurring need for filtration consumables, such as membranes, cartridges, and cassettes in the pharmaceutical manufacturing process. Unlike capital equipment that has a long lifecycle, consumables are used in a single manufacturing cycle and need frequent replacement, ensuring a consistent demand. Furthermore, the increasing adoption of single-use technologies, particularly in bioprocessing, amplifies the need for disposable filtration consumables, which are viewed as more convenient and less prone to cross-contamination. In addition, regulatory bodies are continually tightening the guidelines for viral safety in biopharmaceutical products, which, in turn, necessitates the use of high-quality consumables that meet these stringent standards. Moreover, the growing development and manufacturing of vaccines and therapies, especially during global health crises, including pandemics, drastically increase the consumption of these disposable products.

Breakup by Application:

Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Others
Medical Devices
Water Purification
Air Purification
Others

Biologicals account for the majority of the market share

The biologicals segment is a key application area driving the market, primarily due to the rising demand for biotherapeutic products, such as monoclonal antibodies, vaccines, and gene therapies. These complex molecules are produced in living cells, making them vulnerable to viral contamination, thereby necessitating robust filtration processes. Along with this, regulatory scrutiny over the safety of biological products is intensifying, with agencies mandating rigorous viral clearance steps. These regulatory imperatives enforce stringent quality controls, propelling the adoption of advanced virus filtration technologies in the biologicals domain. In addition, the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune conditions has also amplified the need for biotherapeutic treatments. Moreover, pharmaceutical companies are ramping up their production capacities and implementing state-of-the-art filtration methods to meet both consumer demand and regulatory requirements.

Breakup by End Use:

Biopharmaceuticals and Biotechnology Companies
Contract Research Organizations
Academic Institutes and Research Laboratories
Others

Biopharmaceuticals and biotechnology companies hold the largest market share

The escalating demand for biopharmaceuticals and the rapid growth of biotechnology companies serve as pivotal market drivers in the virus filtration industry. These entities are at the forefront of developing complex biological products such as monoclonal antibodies, vaccines, and recombinant proteins, which are inherently susceptible to viral contamination. Additionally, the imperative for ensuring product safety and efficacy is a scientific necessity and a regulatory mandate. In confluence with this, organizations are setting stringent guidelines that require the application of robust virus filtration processes for quality assurance. As biopharmaceuticals become increasingly central in treating a range of diseases, from chronic conditions to pandemic-related illnesses, the need for effective virus filtration grows proportionally. Furthermore, advancements in biotechnology, such as CRISPR and gene therapy, have further extended the scope and complexity of bioproducts, subsequently amplifying the necessity for advanced virus filtration solutions.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest virus filtration market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest segment.

The market in North America is experiencing significant growth, propelled by a favorable environment for industry expansion. One of the leading drivers is the robust presence of global biopharmaceutical companies and advanced research institutions in the region, which necessitates high-quality virus filtration solutions for product safety. Along with this, regulatory frameworks set by agencies are enforcing stringent guidelines on viral clearance, thereby elevating the demand for efficient filtration technologies. In addition, North America has been a pioneer in biotechnological advancements, contributing to the development of new therapies, vaccines, and other bioproducts that require virus filtration.

Besides this, considerable growth in the investment in healthcare research and development is substantial in this region, further fueling the growth of the market. The occurrence of global health crises, such as pandemics, often leads to a rapid scale-up in vaccine and therapeutic production, dramatically increasing the need for reliable virus filtration systems. All these elements converge to make North America a strong market for virus filtration technologies, driving both innovation and adoption in the industry.

Competitive Landscape:

The key players are continually working on developing more efficient and reliable filtration technologies. This includes innovations in filter membranes, filtration systems, and single-use technologies to provide better solutions to clients. Along with this, the major companies are offering products and services that meet or exceed these regulations, often providing robust validation support for their customers. In addition, companies are entering into strategic partnerships or acquisitions to expand their geographical reach and product portfolio. Apart from this, several brands are offering consultancy services alongside their products to help customers optimize their filtration processes, which is acting as another growth-inducing factor. With an increasing focus on environmental responsibility, some companies are exploring and developing more sustainable filtration technologies, such as reusable or recyclable filter components.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Asahi Kasei Medical Co. Ltd.
Charles River Laboratories Inc.
Clean Cells
Danaher Corporation
Merck KGaA
Sartorius AG
Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1.What was the size of the global virus filtration market in 2024?
2.What is the expected growth rate of the global virus filtration market during 2025-2033?
3.What are the key factors driving the global virus filtration market?
4.What has been the impact of COVID-19 on the global virus filtration market?
5.What is the breakup of the global virus filtration market based on the product?
6.What is the breakup of the global virus filtration market based on the application?
7.What is the breakup of the global virus filtration market based on the end use?
8.What are the key regions in the global virus filtration market?
9.Who are the key players/companies in the global virus filtration market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Virus Filtration Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Kits and Reagents
  - 6.1.2.2 Others
- 6.1.3 Market Forecast
6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Major Types
  - 6.2.2.1 Filtration Systems
  - 6.2.2.2 Chromatography Systems
- 6.2.3 Market Forecast
6.3 Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Application

7.1 Biologicals
- 7.1.1 Market Trends
- 7.1.2 Major Types
  - 7.1.2.1 Vaccines and Therapeutics
  - 7.1.2.2 Blood and Blood Products
  - 7.1.2.3 Cellular and Gene Therapy Products
  - 7.1.2.4 Others
- 7.1.3 Market Forecast
7.2 Medical Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Water Purification
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Air Purification
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End Use

8.1 Biopharmaceuticals and Biotechnology Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Contract Research Organizations
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Academic Institutes and Research Laboratories
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Asahi Kasei Medical Co. Ltd.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Charles River Laboratories Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Clean Cells
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Danaher Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Merck KGaA
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Sartorius AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Thermo Fisher Scientific Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Virus Filtration Market: Major Drivers and Challenges
Figure 2: Global: Virus Filtration Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Virus Filtration Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Virus Filtration Market: Breakup by Product (in %), 2024
Figure 5: Global: Virus Filtration Market: Breakup by Application (in %), 2024
Figure 6: Global: Virus Filtration Market: Breakup by End Use (in %), 2024
Figure 7: Global: Virus Filtration Market: Breakup by Region (in %), 2024
Figure 8: Global: Virus Filtration (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Virus Filtration (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Virus Filtration (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Virus Filtration (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Virus Filtration (Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Virus Filtration (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Virus Filtration (Biologicals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Virus Filtration (Biologicals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Virus Filtration (Medical Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Virus Filtration (Medical Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Virus Filtration (Water Purification) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Virus Filtration (Water Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Virus Filtration (Air Purification) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Virus Filtration (Air Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Virus Filtration (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Virus Filtration (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Virus Filtration (Biopharmaceuticals and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Virus Filtration (Biopharmaceuticals and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Virus Filtration (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Virus Filtration (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Virus Filtration (Academic Institutes and Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Virus Filtration (Academic Institutes and Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Virus Filtration (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Virus Filtration (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: North America: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: North America: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: United States: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Asia-Pacific: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Asia-Pacific: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: China: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Europe: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Europe: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Germany: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Latin America: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Latin America: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Brazil: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Middle East and Africa: Virus Filtration Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Middle East and Africa: Virus Filtration Market: Breakup by Country (in %), 2024
Figure 80: Middle East and Africa: Virus Filtration Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Global: Virus Filtration Industry: SWOT Analysis
Figure 82: Global: Virus Filtration Industry: Value Chain Analysis
Figure 83: Global: Virus Filtration Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Virus Filtration Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Virus Filtration Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Virus Filtration Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Virus Filtration Market Forecast: Breakup by End Use (in Million USD), 2025-2033
Table 5: Global: Virus Filtration Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Virus Filtration Market: Competitive Structure
Table 7: Global: Virus Filtration Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

2025 年至 2033 年病毒过滤市场规模、份额、趋势及预测（依产品、应用、最终用途及地区划分）

Virus Filtration Market Size, Share, Trends and Forecast by Product, Application, End Use, and Region, 2025-2033

病毒过滤市场趋势/驱动因素：

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：简介

第五章：全球病毒过滤市场

第六章：市场区隔：依产品

第七章：市场区隔：依应用

第 8 章：市场区隔：最终用途别

第九章：市场细分：依地区

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局